Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits
- PMID: 6826714
- PMCID: PMC436888
- DOI: 10.1172/jci110785
Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits
Abstract
A rabbit model of pneumococcal meningitis was used to examine the importance of bactericidal vs. bacteriostatic antimicrobial agents in the therapy of meningitis 112 animals were infected with one of two strains of type III Streptococcus pneumoniae. Both strains were exquisitely sensitive to ampicillin, minimum inhibitory concentration (MIC)/minimum bactericidal concentration (MBC)<0.125 mug/ml. The activity of chloramphenicol against the two strains varied: strain(1)-MIC 2 mug/ml, MBC 16 mug/ml; strain(2)-MIC 1 mug/ml, MBC 2 mug/ml. Animals were treated with either ampicillin or chloramphenicol in dosages that achieved a peak bactericidal effect in cerebrospinal fluid (CSF) for ampicillin against both strains. Two different dosages were used for chloramphenicol. The first dosage achieved a peak CSF concentration of 4.4+/-1.1 mug/ml that produced a bacteriostatic effect against strain(1) and bactericidal effect against strain(2). The second dosage achieved a bactericidal effect against both strains (mean peak CSF concentration 30.0 mug/ml). All animals were treated intramuscularly three times a day for 5 d. CSF was sampled daily and 3 d after discontinuation of therapy for quantitative bacterial cultures. Results demonstrate that only antimicrobial therapy that achieved a bactericidal effect in CSF was associated with cure. Over 90% of animals treated with one of the bactericidal regimens (i.e., animals in which the bacterial counts in CSF dropped >5 log(10) colony-forming units [cfu]/ ml after 48 h) had sterile CSF after 5 d of treatment. On the other hand, the regimen that achieved bacteriostatic concentrations (CSF drug concentrations between the MIC and MBC) produced a drop of 2.4 log(10) cfu/ml by 48 h; however, none of the animals that survived had sterile CSF after 5 d. These studies clearly demonstrate in a strictly controlled manner that maximally effective antimicrobial therapy of experimental pneumococcal meningitis depends on achieving a bactericidal effect in CSF.
Similar articles
-
Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis.J Antimicrob Chemother. 1995 Dec;36(6):997-1004. doi: 10.1093/jac/36.6.997. J Antimicrob Chemother. 1995. PMID: 8821598
-
Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo.Rev Infect Dis. 1981 Jan-Feb;3(1):98-109. doi: 10.1093/clinids/3.1.98. Rev Infect Dis. 1981. PMID: 7221361
-
Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children.Pediatr Infect Dis. 1985 Jul-Aug;4(4):362-8. doi: 10.1097/00006454-198507000-00006. Pediatr Infect Dis. 1985. PMID: 3895175 Clinical Trial.
-
Pharmacodynamics of gatifloxacin in experimental models of pneumococcal meningitis.Clin Infect Dis. 2000 Aug;31 Suppl 2:S45-50. doi: 10.1086/314060. Clin Infect Dis. 2000. PMID: 10984328 Review.
-
Pharmacokinetic and bacteriological correlations between antimicrobial therapy of experimental meningitis in rabbits and meningitis in humans: a review.J Antimicrob Chemother. 1983 Dec;12 Suppl D:97-108. doi: 10.1093/jac/12.suppl_d.97. J Antimicrob Chemother. 1983. PMID: 6365874 Review.
Cited by
-
New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits.Antimicrob Agents Chemother. 1985 Mar;27(3):340-2. doi: 10.1128/AAC.27.3.340. Antimicrob Agents Chemother. 1985. PMID: 3838872 Free PMC article.
-
Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.Antimicrob Agents Chemother. 1987 Apr;31(4):518-22. doi: 10.1128/AAC.31.4.518. Antimicrob Agents Chemother. 1987. PMID: 3300530 Free PMC article.
-
Potential role of fluoroquinolones in the treatment of bacterial meningitis.Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):291-5. doi: 10.1007/BF01967002. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1864289 Review.
-
Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance.Emerg Infect Dis. 2003 Jan;9(1):10-6. doi: 10.3201/eid0901.020172. Emerg Infect Dis. 2003. PMID: 12533275 Free PMC article. Review.
-
Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation.J Clin Invest. 1986 Apr;77(4):1084-95. doi: 10.1172/JCI112407. J Clin Invest. 1986. PMID: 3514671 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources